Site of Manufacture of Active mRNA Ingredient for Pfizer Covid Vaccine Batches

Catherine Jamieson made this Official Information request to Ministry of Health

Currently waiting for a response from Ministry of Health, they must respond promptly and normally no later than (details and exceptions).

From: Catherine Jamieson

Dear Ministry of Health,

Prior to 6 October 2021 import of Comirnaty into New Zealand was limited to that where the active mRNA ingredient was manufactured at the following sites:-

1) Wyeth Biopharma, Division of Wyeth Pharmaceuticals LLC
One Burtt Road, Andover Massachussetts 01810 United States of America
2) Rentschler Biopharma SE Erwin-Rentschler-Strasse 21 Laupheim 88471
Germany
3) BioNTech Manufacturing GmbH An der Goldgrube 12
Mainz 5513, Germany

For the following batches of Comirnaty please identify the site of manufacture of the active mRNA ingredient:-

EP2163, EP9605, ER7449, ET3045, FA5833, FC3558, FC5029, FD0927, FD9234, FE2090, FE3064, FE8163, FF2382, FF4206, FF4222, FF8871, FG0050, FG3716, FG7372, FG9019, FH0114, FH3219, FH4091, FH4092

If the site of manufacture of final dose form for any of the above batches differs from

Pfizer Manufacturing Belgium NV Rijksweg 12, Puurs B-2870, Belgium

please identify which batches this applies to and provide identifying name and address of the respective sites.

Yours faithfully,

Catherine Jamieson

Link to this

From: OIA Requests


Attachment image.png
89K Download


Kia ora Catherine,

  

Thank you for your request for official information. The reference number
for your request is: H2024041454

  

As required under the Official Information Act 1982, Manatū Hauora will
endeavour to respond to your request no later than 20 working days after
the day your request was received. If you'd like to calculate the
timeframe, you can use the Ombudsman's online calculator
here: [1]http://www.ombudsman.parliament.nz/  

  

If you have any queries, please feel free to contact the OIA Services Team
on [2][email address]. If any additional factors come to light which
are relevant to your request, please do not hesitate to contact us so that
these can be taken into account.  

Under section 28(3) of the Act you have the right to ask the Ombudsman to
review any decisions made under this request. The Ombudsman may be
contacted by email at: [3][email address] or by calling 0800
802 602.

Ngā mihi 

 

OIA Services Team 

[4]Ministry of Health information releases 

 

 

------------------- Original Message

show quoted sections

Link to this

Things to do with this request

Anyone:
Ministry of Health only: